Urban Skantze

Title: Urban Skantze: Innovator in Pharmaceutical Formulations

Introduction

Urban Skantze is a notable inventor based in Södertälje, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid formulations for specific compounds. His work is recognized for its potential impact on drug delivery and efficacy.

Latest Patents

Urban Skantze holds a patent for "Solid pharmaceutical formulations of 6-(2-chloro-6-methylpyridin-4-yl)-5-(4-fluorophenyl)-1,2,4-triazin-3-amine." This patent describes solid pharmaceutical formulations that include AZD4635. The formulations can incorporate a polymeric stabilizer, such as polyvinylpyrrolidone, an ionic surfactant like sodium docusate, and a non-ionic surfactant such as poloxamer. This innovation is crucial for enhancing the stability and effectiveness of pharmaceutical products.

Career Highlights

Urban Skantze is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to contribute to the advancement of pharmaceutical sciences and improve patient outcomes through innovative drug formulations.

Collaborations

Throughout his career, Urban has collaborated with esteemed colleagues, including Anders Holmgren and Annika Kyssä. These collaborations have fostered a productive environment for innovation and research within the pharmaceutical sector.

Conclusion

Urban Skantze's contributions to pharmaceutical formulations exemplify the importance of innovation in drug development. His work continues to influence the industry and improve therapeutic options for patients.